Erratum to 'Reply to: Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients': [ESMO Open Volume 7, Issue 1, February 2022, 100393]
ESMO Open. 2022 Apr;7(2):100460.
doi: 10.1016/j.esmoop.2022.100460.
Epub 2022 Mar 17.
1 UC Davis Comprehensive Cancer Center, Sacramento; University of California, San Francisco School of Pharmacy, San Francisco. Electronic address: [email protected].
2 Department of Pharmacy, Oregon Health and Science University, Portland.
3 UC Davis Comprehensive Cancer Center, Sacramento; Division of Hematology and Oncology, University of California Davis Comprehensive Cancer Center, University of California Davis School of Medicine, Sacramento, USA.